Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 29, 2010 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Files New Drug Application for Ceplene in AML

EpiCept Files New Drug Application for Ceplene in AML Priority Review Requested TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and...
June 28, 2010 17:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Present at the OneMedForum New York 2010

EpiCept to Present at the OneMedForum New York 2010 Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) today announced that Jack Talley, President and CEO, will be...
June 28, 2010 02:37 ET | Source: Immune Pharmaceuticals Inc

EpiCept Announces Pricing of Public Offering

EpiCept Announces Pricing of Public Offering TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT)...
June 15, 2010 23:45 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation Amends Chief Executive Officer's Employment Agreement

EpiCept Corporation Amends Chief Executive Officer's Employment Agreement TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and OMX...
June 15, 2010 00:04 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation Added to Preliminary List of Companies in Russell Microcap Index

EpiCept Corporation Added to Preliminary List of Companies in Russell Microcap Index TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--Regulatory News: EpiCept Corporation (Nasdaq and...
June 09, 2010 00:02 ET | Source: Immune Pharmaceuticals Inc

Epicept Corporation Reports Results of Annual Meeting of Stockholders

Epicept Corporation Reports Results of Annual Meeting of Stockholders TARRYTOWN, N.Y. (June 9, 2010) - EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today the results of its...
June 01, 2010 00:12 ET | Source: Immune Pharmaceuticals Inc

EpiCept Announces Fulfillment of Ceplene's Third European Post-Approval Commitment

EpiCept Announces Fulfillment of Ceplene's Third European Post-Approval Commitment EMA Agrees Confirmatory Trial Not Needed or Feasible TARRYTOWN,...
May 28, 2010 00:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept Announces Webcast of Annual Shareholder Meeting

EpiCept Announces Webcast of Annual Shareholder Meeting TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm...
May 26, 2010 00:10 ET | Source: Immune Pharmaceuticals Inc

Targeted Patient Enrollment Reached in Phase IIb Clinical Trial for Epicept™ NP-1 in Chemotherapy-Induced Peripheral Neuropathy

Targeted Patient Enrollment Reached in Phase IIb Clinical Trial for Epicept™ NP-1 in Chemotherapy-Induced Peripheral Neuropathy TARRYTOWN, N.Y.--(BUSINESS...
May 21, 2010 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation Announces Commercial Launch of Ceplene® in Germany

EpiCept Corporation Announces Commercial Launch of Ceplene® in Germany TARRYTOWN, N.Y.--(BUSINESS WIRE)--EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) today announced the...